Arteriocyte Medical Systems is a medical device company developing innovative solutions to improve the outcomes of surgical procedures.
Arteriocyte Medical Systems, Inc. is a leading medical device company dedicated to helping patients heal faster by developing innovative solutions to improve the outcomes of surgical procedures based on cell and tissue based therapies.The Company’s lead product is the Magellan® Autologous Platelet Separator. The Magellan® System provides surgeons the ability to fractionate peripheral blood and/or aspirated bone marrow from a patient, for that patient, at bedside in approximately 15 minutes using a fully automated closed loop separation process. The Magellan® device yields a 3-10cc injectable unit of platelet and stem cell enriched plasma for the surgeon’s use in his or her procedure.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 15, 2008 | Grant | $509K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Global Cardiovascular Innovation Center | — | Grant |